Investigating the Use of TGF-ß2 to Downregulate MHC Expression and Reduce the Immunogenicity of Equine Bone Marrow-derived Mesenchymal Stem Cells.
dc.contributor.advisor | Lauren Schnabel, Co-Chair | |
dc.contributor.advisor | Samuel Jones, Co-Chair | |
dc.contributor.advisor | Jonathan Fogle, Member | |
dc.contributor.advisor | Ke Cheng, Member | |
dc.contributor.advisor | Matthew Fisher, Member | |
dc.contributor.author | Berglund, Alix Kay | |
dc.date.accepted | 2018-03-09 | |
dc.date.accessioned | 2018-04-06T12:33:23Z | |
dc.date.available | 2018-04-06T12:33:23Z | |
dc.date.defense | 2018-02-28 | |
dc.date.issued | 2018-02-28 | |
dc.date.released | 2018-04-06 | |
dc.date.reviewed | 2018-03-02 | |
dc.date.submitted | 2018-03-01 | |
dc.degree.discipline | Comparative Biomedical Sci | |
dc.degree.level | dissertation | |
dc.degree.name | Doctor of Philosophy | |
dc.identifier.other | deg7971 | |
dc.identifier.uri | http://www.lib.ncsu.edu/resolver/1840.20/35051 | |
dc.rights | ||
dc.title | Investigating the Use of TGF-ß2 to Downregulate MHC Expression and Reduce the Immunogenicity of Equine Bone Marrow-derived Mesenchymal Stem Cells. |
Files
Original bundle
1 - 1 of 1